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Abstract The biological activity of connective tissue growth
factor (CTGF, CCN2) is regulated at the level of intracellular
signaling leading to gene expression, and by its extracellular
interaction partners which determine the functional outcome
of CCN2 action. In this overview, we summarize the data
which provide evidence that one of the major signaling
pathways, phosphatidylinositol-3 kinase (PI3K)–AKTsignal-
ing, shows a remarkable cell type-dependence in terms of
regulation of CCN2 expression. In smooth muscle cells,
fibroblasts, and epithelial cells, inhibition of this pathway
either reduced CCN2 expression or was not involved in
CCN2 gene expression depending on the stimulus used. In
microvascular endothelial cells by contrast, activation of
PI3K–AKT signaling was inversely related to CCN2 expres-
sion. Upregulation of CCN2 upon inhibition of PI3K–AKT
was also observed in primary cultures of human endothelial
cells (HUVEC) exposed to laminar flow in an in vitro flow-
through system. In different types of endothelial cells, FoxO
transcription factors, which are negatively regulated by AKT,
were identified as potent activators of CCN2 gene expression.
In HUVEC, we observed a correlation between enhanced
nuclear localization of FoxO1 and increased synthesis of
CCN2proteininareasofnon-uniformshearstress.Thesedata
indicate that FoxO proteins are key regulators of CCN2 gene
expression which determine the effect of PI3K–AKT activa-
tion in terms of CCN2 regulation. Short summary
Phosphatidylinositol-3 kinase (PI3K)–AKT signaling shows
a remarkable cell type-dependence in terms of regulation of
CCN2 expression. In endothelial cells activation of PI3K -
AKT signaling was inversely related to CCN2 expression.
FoxO transcription factors, which are negatively regulated





CCN2 Connective tissue growth factor
CTGF; HUVEC Human umbilical vein endothelial cells
PI3K Phosphatidylinositol-3 kinase
TGF Transforming growth factor
Introduction
Connective tissue growth factor (CTGF, CCN2) is a
multifunctional protein, which is secreted and functions as
a matricellular protein. Accordingly, the biological activity
of CCN2 is regulated both at the level of intracellular
signaling leading to gene expression, and by its extracellu-
lar interaction partners, which determine the functional
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have been related to CCN2 gene expression, some of
which, such as transforming growth factor (TGF)beta—
Smad signaling, seem to work in different cell types, or are
shared by multiple stimuli, such as activation of RhoA Rho-
kinase signaling (Chaqour and Goppelt-Struebe 2006;
Cicha & Goppelt-Struebe 2009). Other pathways leading
to CCN2 induction seem to be rather specifically detected
in a restricted number of cell types, for example, activation
of Rac-1 has only been related to CCN2 expression in
gingival fibroblasts and chondrocytes (Black and Trackman
2008; Woods et al. 2009). In this brief overview, we will
concentrate on the impact of the activation of one of the
major signaling pathways, which is operative in all cells,
namely phosphatidylinositol-3 kinase (PI3K)–AKT signal-
ing on CCN2 gene expression. We will summarize the
published data and present evidence for cell type-specific
regulation of CCN2 by PI3K–AKT signaling.
Activation of AKT may lead to the modulation of
multiple pathways, giving rise to a highly complex
signaling network (e.g. (Jiang and Liu 2008; Chaqour et
al. 2006)). In smooth muscle cells either exposed to
mechanical stretch (Chaqour et al. 2006) or activated by
serum or sphingosine-1 phosphate (Chowdhury and
Chaqour 2004), PI3K–AKT signaling contributed to
CCN2 promoter activation. By contrast, inhibition of
PI3K did not interfere with TGFbeta-induced CTGF
induction in lung fibroblasts (Xie et al. 2005). In line with
these data, we did not observe a role of PI3K–AKT
signaling for CCN2 expression in tubular epithelial cells
stimulated with hepatocyte growth factor, which is known
to activate AKT (Kroening et al. 2009). In experiments with
renal fibroblasts stimulated with the microtubule disrupting
agent colchicine, we observed that the response of the cells
depended on the cell culture conditions: When the cells
were cultured on a rigid surface, upregulation of CCN2
gene expression was independent of PI3K–AKT signaling,
whereas inhibitors of PI3K significantly reduced CTGF
gene expression, when the cells were cultured in collagen
gels (Graness et al. 2006). This differential reactivity may
be related to the link between focal adhesion kinase and
PI3K, which plays a role in the survival of fibroblasts in
collagen gels (Xia et al. 2004). Analyzing VEGF-dependent
induction of CCN2, Suzuma et al. observed inhibition of
CCN2 gene expression upon interference with AKT
signaling in bovine retinal endothelial cells (Suzuma et al.
2000). However, the downstream mediators of AKT
signaling were not investigated in this or in any of the
other studies. In recent studies with different microvascular
endothelial cell lines we demonstrated that PI3K–AKT may
also negatively regulate CCN2 expression as discussed in
detail below (Samarin et al. 2009). To extend these
findings, we investigated the regulation of CCN2 expres-
sion in primary cultures of human umbilical vein endothe-
lial cells (HUVEC) cultured under flow conditions which
more closely resemble the in vivo conditions compared to
static culture conditions.
Methods
HUVEC were isolated from freshly delivered umbilical
cords and grown on 0.1% gelatin-coated dishes as
described (Muehlich et al. 2004). HUVEC were seeded in
flow-through cell culture slides (Ibidi®, Munich, Germany)
and exposed to steady laminar shear stress for 20 h at
10 dyne/cm
2 (Cicha et al. 2008). Bifurcating slides were
used to analyze cells exposed to non-uniform shear stress.
Protein expression was detected by indirect immunocyto-
chemistry with the following antibodies: polyclonal goat
anti-CTGF (1:100; Santa Cruz), anti-goat IgG coupled to
Alexa Fluor 488 (1:500; Molecular Probes), polyclonal
rabbit anti-FoxO1 (1:100, Cell Signaling) and anti-rabbit
IgG coupled to Alexa Fluor 555 (1:500, Molecular Probes).
Images were obtained using an inverted fluorescence
microscope combined with a digital camera and Meta-
Morph software. For quantification, MetaVue software was
used as described in detail in (Cicha et al. 2008).
To downregulate FoxO1 and FoxO3a expression,
HUVEC were transfected with equal concentrations
(50 nM each) of FoxO1 and FoxO3a siRNA or luciferase
siRNA (Eurogentec, Seraing, Belgium) using Lipofect-
amine 2000 (Invitrogen). The following siRNAs were used:
FoxO1 sense GCG-GGC-UGG-AAG-AAU-UCA-A;
FoxO3a sense GCU-CUU-GGU-GGA-UCA-UCA-A. 24 h
after transfection, the cells were exposed to flow.
Results
CCN2 expression in HUVEC cultured under static con-
ditions is very high, in contrast to the low expression
detectable in the endothelial lining of healthy vessels.
Therefore, CCN2 expression was analyzed in cells pre-
exposed tophysiologiclevelsoflaminar flow (10dyne/cm
2).
Compared to cells cultured under static conditions, CCN2
is downregulated under these conditions (Fig. 1 and (Cicha
et al. 2008)). Following 18 h pre-conditioning with laminar
flow, the cells were treated with a specific inhibitor of
PI3K, LY294002 (10µM), for additional 2 h at flow.
Inhibition of PI3K–AKT signaling led to a robust upregu-
lation of CCN2 protein expression (Fig. 1). CCN2
expression was detectable in a perinuclear Golgi localiza-
tion, as observed earlier (Samarin et al. 2009). These data
thus showed that negative regulation of CCN2 by PI3K–
AKT signaling was not restricted to microvascular endo-
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HUVEC studied under physiological flow conditions.
Transcription factors of the FoxO family are activated
upon inhibition of PI3K–AKT signaling. Our previous data
obtained in microvascular endothelial cells showed that
these transcription factors are involved in the regulation of
CCN2 expression (Samarin et al. 2009; Komorowsky et al.
2009). Therefore, we used an siRNA approach to analyze
the role of FoxO transcription factors in HUVEC. FoxO1
was readily detectable in HUVEC by Western blot analysis
and by immunocytochemistry (Fig. 2 and data not shown),
whereas FoxO3a was barely detectable. However, it has
been reported that these FoxO proteins can compensate one
another (Potente et al. 2005). To avoid this potential
compensating effect, we used a mixture of siRNAs directed
against FoxO1 and FoxO3a.
Treatment of HUVEC exposed to laminar flow with the
PI3K inhibitor LY294002 for 2 h led to nuclear localization
of FoxO1 in all cells transfected with luciferase siRNA
(Fig. 2, upper panel). In samples transfected with FoxO1/3a
siRNA, nuclear localization of FoxO1 was only detectable
in few cells (Fig. 2, lower panel). These cells expressed
CCN2 at levels comparable to control HUVEC. By
contrast, downregulation of FoxO1 by siRNA transfection
was associated with a reduced expression of CCN2.
We have reported earlier that CCN2 is downregulated
under laminar flow and upregulated when HUVEC are
exposed to non-uniform shear stress (Cicha et al. 2008).
Interestingly, FoxO1 was barely detectable in cells exposed
to laminar shear stress, whereas it was localized to the
nucleus in cells exposed to non-uniform shear stress
(Fig. 3). Nuclear localization of FoxO1 correlated with an
increased expression of CCN2 under in vivo-like hemody-
namic conditions, suggesting a role of FoxO proteins in
CCN2 regulation by non-uniform shear stress.
Discussion
Regulation of CCN2 expression via PI3K–AKT signaling
shows a remarkable cell type- and context-dependence. As
outlined in the introduction, there is good evidence in the
literature that activation of AKT is related to increased
CCN2 expression. However, the molecular details of this
activation remain to be defined. AKT activity is modulated
by several binding partners which modulate signaling
downstream of PI3K (Franke 2008). It is also unknown
which of the multiple downstream mediators of AKT can
actually lead to the increased CCN2 gene expression.
Our previously published data summarized in this report,
provide evidence that PI3K–AKT negatively regulates
CCN2 expression in endothelial cells. Upregulation rather
than downregulation of CCN2 upon inhibition of PI3K–
AKT signaling was observed in mouse microvascular
endothelial cell lines obtained from heart or kidney
(Samarin et al. 2009). This indicated that active AKT
Fig. 1 Inhibition of PI3K increases CCN2 expression in HUVEC
exposed to laminar shear stress. a HUVEC were seeded in flow-
through cell culture slides and exposed to steady laminar shear stress
for 20 h at 10 dyne/cm
2. For the last 2 h of flow, PI3K–AKT signaling
was inhibited by treatment with LY294002 (10µM). Protein expres-
sion was determined by immunofluorescence. Photos are representa-
tive of two independent experiments performed in duplicate. b Data
quantification: six to seven images at objective magnification 20×
were taken for every experiment, and analyzed using MetaVue
software. The thresholded protein expression levels were expressed
as arbitrary fluorescence units. ***P<0.001; t-test vs. untreated
controls, n=2 with duplicate cell culture slides






Fig. 3 FoxO1 expression depends on flow conditions and is
associated with CCN2 induction by non-uniform shear stress. HUVEC
were seeded in bifurcating flow-through slides as described in detail in
(Cicha et al. 2008). Cells were exposed to flow for 20 h. Photos were
taken in areas of laminar shear stress (upper panel) or areas of non-
uniform shear stress (lower panel). CCN2 and FoxO1 were detected
by indirect immunofluorescence. Images showing nuclear FoxO1
expression were inverted. Color figures showing the merged images







Fig. 2 FoxO1 is involved in CCN2 regulation in HUVEC. HUVEC were
transfected with siRNA against luciferase or FoxO1 and FoxO3a 24 h after
seeding.Thenextdaythecellswereexposedtolaminarshearstressfor18h
and then treated with LY294002 (10µM for 2 h). CCN2 and FoxO1 were
detected by indirect immunofluorescence. Images showing nuclear FoxO1
expression were inverted. Arrows indicate cells with barely detectable
FoxO1 expression and low levels of CCN2 expression. Color figures
showing the merged images are provided as “Supplemental data”
82 J. Samarin et al.signaling prevented rather than simulated CCN2 gene
expression in these cells. We now confirmed these
observations in primary cultures of HUVEC exposed to
laminar flow. Regarding the mechanisms of regulation,
activated AKT can negatively modulate gene expression by
recruiting FoxO transcription factors from the nucleus to
the cytoplasm. FoxO transcription factors are important
regulators of endothelial cell differentiation, angiogenesis,
and maintenance of vascular homeostasis (Potente et al.
2005; Dejana et al. 2007). Interestingly, the function of
FoxO proteins is highly context-specific and can differ even
in endothelial cells obtained from different vascular beds
(Paik et al. 2007), which may explain the apparently
discrepant results obtained by Suzuma et al. (Suzuma et
al. 2000). FoxO proteins localize to the cytosol upon
phosphorylation, whereas dephosphorylated FoxO proteins
localize to the nucleus and are active as transcription
factors. Using an siRNA approach, we previously showed
that these transcription factors play a central role in CCN2
induction in endothelial cells (Samarin et al. 2009;
Komorowsky et al. 2009). Upregulation of CCN2 by
inhibition of PI3K–AKT signaling was almost completely
inhibited in the presence of siRNA against FoxO1 and
FoxO3a in microvascular endothelial cells (Samarin et al.
2009) and, as shown in this study, in HUVEC. Further-
more, knock-down of FoxOs affected the induction of
CCN2 by various stimuli, e.g. TGFbeta (Komorowsky et al.
2009) and hypoxia (unpublished observation).
FoxOs are not only phosphorylated by AKT but also by
other kinases. AMP-activated protein kinase (AMPK) was
shown to phosphorylate and thus inactivate FoxO1 in
HUVEC exposed to laminar shear stress (Dixit et al. 2008).
In line with these results FoxO1 was barely detectable in
HUVEC exposed to laminar shear stress. However, nuclear
localization was observed in HUVEC exposed to non-
uniform shear stress. Whether this was related to an
inhibition of AMPK remains to be investigated. Interest-
ingly, there was a close correlation between nuclear FoxO1
localization and CCN2 expression, suggesting that the role
of FoxOs in CCN2 regulation goes beyond PI3K–AKT
signaling.
FoxO proteins as transcription factors have been shown
to bind to coactivator and corepressor complexes. These
interactions are modulated by the posttranscriptional mod-
ification state of FoxOs, which involves acetylation and
ubiquitination besides phosphorylation (Vogt et al. 2005).
There are several putative FoxO binding sites in the core
promoter of CCN2 (Gomis et al. 2006), but the complexes
formed with other transcripiton factors have not yet been
analyzed in detail. The molecular details of FoxO-mediated
upregulation of CCN2 thus remain to be investigated.
In accordance with our results, microarray data showed
that upon overexpression of constitutively active AKT,
CCN2 was downregulated, whereas active FoxO1 upregu-
lated CCN2 in HUVEC (Daly et al. 2004). In human
keratinocytes, CCN2 was identified as a member of a
FoxO-Smad synergism group, i.e. proteins which were
upregulated by TGFbeta in a Smad- and FoxO-dependent
manner (Gomis et al. 2006). These data indicate that FoxO
proteins may play an important role in the regulation of
CCN2 in other cell types besides endothelial cells.
In summary, regulation of CCN2 expression via PI3K–
AKT signaling varies depending on the cell type and the
cell culture conditions. In endothelial cells, activation of
PI3K–AKT suppresses CCN2 expression, whereas inhibi-
tion of AKT activates FoxO transcription factors, which
serve as potent inducers of CCN2 gene expression. FoxO
proteins are thus key regulators which determine the effects
of the activation of PI3K–AKT signaling on CCN2 gene
expression.
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